https://www.avient.com/sites/default/files/2023-07/Avient_CodeConduct_2023_Portuguese.pdf
Nossa integridade pessoal é a base para a reputação da Avient e a integridade desenvolve credibilidade.
19
Negociação justa
Vendemos nossos produtos e serviços com base nos
seus méritos.
Concorrência
A Avient esforça-se para obter negócios com base
em produtos, serviços e desempenho superiores.
A Avient faz comparações justas e com base em
fatos do desempenho de produtos.
https://www.avient.com/sites/default/files/resources/Clinton%2520IATF%252016949-2016%2520exp%25207-2-2021.pdf
ECert.pdf
Page 1 of 2
Validity of this certificate is based on the successful completion of the periodic surveillance audits of the management system defined by the above scope and is contingent upon
prompt,written notification to ABS Quality Evaluations, Inc. of significant changes to the management system or components thereof.
https://www.avient.com/sites/default/files/2023-03/63431-ECert.pdf
ECert.QECertificate
Page 1 of 2
Validity of this certificate is based on the successful completion of the periodic surveillance audits of the management system defined by the above scope and is contingent upon
prompt,written notification to ABS Quality Evaluations, Inc. of significant changes to the management system or components thereof.
https://www.avient.com/sites/default/files/2021-01/avient-finland-oy-trade-register-extract-eng-dec-1-2020.pdf
Representation based on position:
By the Chair of the Board and the Managing Director, each on their own, and by any two Board members
jointly
Persons
role surname, first name(s) /
company name
date of birth /
identity code
citizenship
Chair of the Board of
Merklein, Norbert 03.05.1964 Citizen of Germany
Norén, Jenny Eva Kristina 18.06.1975 Citizen of Sweden
Smeds, Jan-Håkan 22.03.1961 Citizen of Finland
Vetter, Alexander Helmut 04.07.1968 Citizen of Germany
Managing Director Norén, Jenny Eva Kristina 18.06.1975 Citizen of Sweden
Auditor PricewaterhouseCoopers Oy 0486406-8
Auditor with principal
responsibility
Grönroos, Maria Alice 19.02.1967 Citizen of Finland
Additional information
No details about beneficial owners have been registered for the company
Name history
Avient Finland Oy 01.12.2020 -
Clariant Plastics & Coatings (Finland) Oy 04.01.2016 - 01.12.2020
Clariant Masterbatches (Finland) Oy 31.03.2007 - 04.01.2016
Source of information: Finnish Patent and Registration Office
https://www.avient.com/sites/default/files/2025-01/ColorMatrix Lactra ESL Infographic.pdf
‘Regular’ milk
• UHT milk
• Flavored milk drinks
• Protein drinks
• Yogurt drinks
• Creams
• Plant-based dairy
• Fermented dairy products
(e.g., kefir, Skyr, labneh, etc.)
• Iced coffee
WHY DO DAIRY PRODUCTS
NEED LIGHT PROTECTION?
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Gabelli%2520%2526%2520Co%2520Specialty%2520Chemicals%2520Conference.pdf
They are based on management’s expectations that
involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those
expressed in or implied by the forward-looking statements.
The New PolyOne: A Specialty Growth Company
Segment Highlights
16POLYONE CORPORATION
1.7%
4.6% 5.1% 5.5%
7.2% 8.1%
9.7%
12.2%
14.7%
16.7%
16.0%
2017 Revenue: $0.9 Billion
United
46%
31%
Asia 15%
Latin
South
(27%)
(14%)
(10%)
Textiles
(12%)
(8%)
15.5%
Color, Additives & Inks
17POLYONE CORPORATION
1.1% 1.3%
3.4%
5.1%
9.6%
8.0% 8.6% 9.3%
12.1%
14.7%
United
48%
28%
22%
(20%)
(19%)
Electrical & Electronics
(15%)
(13%)
(11%)
12.5%
2017 Revenue: $0.6 Billion Operating Income % of Sales
14.3%
Specialty Engineered Materials
18POLYONE CORPORATION
5.5%
6.9%
3.8%
3.6%
5.5%
4.3%
6.3%
7.2% 7.7%
8.3%
12-14%
10.7%
11.1%
United
77%
16% Latin
5%
Building & Construction
(30%)
(16%)
(15%)
(18%)
2017 Revenue: $0.7 Billion Operating Income % of Sales
Performance Products & Solutions
19POLYONE CORPORATION
23%
22%
18%
15% Appliance
7%
E & E
6%
B & C
3%
W & C
38%
ROIC*
2.6% 3.0% 3.5%
4.6%
5.6%
6.4% 5.9% 6.1%
6.6% 6.5 - 7.5%6.3%
*After-Tax ROIC
6.4%
2017 Revenue: $1.2 Billion Key Suppliers
4.0%
Distribution
http://www.polyone.com/Pages/VariationRoot.aspx
http://www.polyone.com/Pages/VariationRoot.aspx
Target End Markets &
Application Examples
21POLYONE CORPORATION
Thermally Conductive
Chemical Resistant
Polymer Colorants
Elastomeric Grips and Handles
Structural Composites
Antimicrobial Technologies
Anti-Counterfeiting
Target End Markets… Healthcare
Catheter Technologies
22POLYONE CORPORATION
Under-hood Components
Target End Markets… Automotive
Interior Structural Components
Sound & Vibration Management
Roof Systems
Air Management
Electronics and Cameras
Lighting
Exterior / Interior Trim
Braces & Brackets
Fasteners
Seals & Flaps
23POLYONE CORPORATION
Target End Markets… Consumer
Thermally Conductive
Components
Polymer Colorants
Elastomeric Grips and
Handles
Structural Composite
Components
24POLYONE CORPORATION
Oxygen Scavenger
Laser Marking Additives
Antistatic Technologies
UV Light Barrier Technologies
Cap & Closure Colorants
Process Optimization
Antioxidant Technologies
Density Modified Technologies
Target End Markets… Packaging
25POLYONE CORPORATION
Impart weight, sound and
metallic finish to caps and
closures for cosmetics and
spirits applications
Elevate quality and prestige
perceptions among high-end
consumers
Eliminate time and cost
associated with secondary
operations and assembly
Luxury Packaging
GravitechTM Density Modified Polymers
26POLYONE CORPORATION
Optimize Color Usage
OnColorTM Super Concentrates
Eliminate costs by increasing
pigment density
Enhance color performance
without altering form and
formulation
Increasing design capabilities
by reducing weight and layer
thickness
27POLYONE CORPORATION
Combat Bacteria Formation
WithStandTM Antimicrobial Technology
Inhibit microbial growth on
polymer surfaces
Enhance value or products
and devices
Highly versatile concentrate
with the ability to be
incorporated into a wide
variety of products
28POLYONE CORPORATION
Medical Device Housings
Chemically Resistant Engineered Polymers
Durable, long-lasting products
stand up to the most
aggressive disinfectants
Minimize environmental
stress cracking and
discoloration
One of the broadest medically
approved polymer and
colorant portfolios
29POLYONE CORPORATION
Color & Design Services
Greater control of color
development and supply chain
Work across entire design
process from concept to
commercialization
Inspire creativity in the use of
polymer materials, colors, and
effects
Innovative brand differentiation
Faster development timelines
30POLYONE CORPORATION
Outdoor Applications
Leading provider of high
performance specialty materials
for the recreational and sports
& leisure industry
Well positioned across all
segments to address market
needs
Metal to Polymer
Conversion
Lightweighting
Thermal Management
Impact Performance
31POLYONE CORPORATION
ColorMatrix Fiber Colorant
Proprietary advanced liquid color
formulations and equipment
enable greater efficiency and
productivity
Eliminates aqueous dyeing and
its associated wastewater
treatment
Solid Color Concentrates
Extrusion-spun fibers colored via
solid masterbatch
Fiber Colorants
32POLYONE CORPORATION
Smart Home Devices
ResilienceTM Vinyl Solutions
High flame retardancy to meet
strict UL standards
Greater processing and design
flexibility
Specialized additives provide
long term color stability
Diffusive lens materials improve
light dispersion
1
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne common shareholders, adjusted earnings per share (EPS)
attributable to PolyOne common shareholders and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) to assess performance and allocate resources
because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.
Senior management believes these measures are useful to investors because they allow for comparison to PolyOne's performance in prior periods without the effect of items
that, by their nature, tend to obscure PolyOne's operating results due to the potential variability across periods based on timing, frequency and magnitude.
https://www.avient.com/sites/default/files/resources/POL%2520Gabelli%2520IR%2520Presentation%2520w%2520Non-GAAP%252003%252020%25202014.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual
results to differ materially from those expressed in or implied by the forward-looking statements.
Use of Non-GAAP Measures
Page 3
PolyOne Commodity to Specialty Transformation
Page 4
• Continue specialty
transformation
• Targeting $2.50
Adjusted EPS by
2015, nearly
double 2013 EPS
• Drive double digit
operating income
and adjusted EPS
growth
• 17 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster
growing, high
margin, less cyclical
end markets
• Key acquisitions
propel current and
future growth, as
well as margin
expansion
• Established
aggressive 2015
targets
• Steve Newlin
Appointed,
Chairman, President
and CEO
• New leadership
team appointed
• Implementation of
four pillar strategy
• Focus on value
based selling,
investment in
commercial
resources and
innovation to drive
transformation
• Volume driven,
commodity
producer
• Heavily tied to
cyclical end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2013 2014 and beyond
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500 Russell 2000 Dow Jones Chemical
All time high of
$38.38
March 7th, 2014
• 17 consecutive quarters of
double digit EPS growth
• 49% CAGR adjusted EPS
expansion 2006-2013
• 2013 stock price increased
73% versus 30% growth in the
S&P
• More than seven fold increase in
market cap: $0.5b $3.6b
Strategy and Execution Drive Results
Page 5
Appliance
4%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
5%
Consumer
10%Packaging
16%
Industrial
12%
HealthCare
11%
Transportation
18%
Misc.
2%
United
States
66%
Europe
14%
Canada
7%
Asia
6%
Latin
America
7%
PP&S
Specialty
53%
Distribution
27%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
1.31
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010 2011 2012 2013 2015
Target
Ad
ju
st
ed
E
ar
ni
ng
s P
er
S
ha
re
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
EPS
Page 6
PolyOne
At A Glance
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34% 43%
62%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2015
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
Specialty OI $5M $46M $87M $195M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 2013 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.2% 12 – 16%
Global Specialty Engineered
Materials 1.1% 9.3% 12 – 16%
Designed Structures & Solutions -- 5.6% 8 – 10%
Performance Products &
Solutions 5.4% 7.2% 9 – 12%
Distribution 2.6% 5.9% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 62% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.1% 15%
4) Adjusted EPS Growth N/A 31% Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
Bridge To $2.50 Adjusted EPS By 2015
2015 EPS: $2.50
2013 EPS: $1.31
Mid single digit
revenue CAGR
Page 9
Mergers & Acquisitions
Spartech accretion
Incremental share buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation &
Mix Improvement
Innovation Drives Earnings Growth
$20.3
$52.3
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
*Percentage of Specialty Platform revenue from products introduced in last five years
Page 10
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
43.0%
2006 2013
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Page 11
Unique and Innovative Solutions that Help
Customers Win
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
Net Debt / EBITDA* = 1.8x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of December 31, 2013
($ millions)
Page 12
Coupon Rates: 7.500% 7.375% 5.250%
Debt Maturities & Pension Funding – 12/31/13
*TTM 12/31/2013 ** includes US-qualified plans only
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2013
Pension Funding**
As of December 31, 2013
Free Cash Flow and Strong Balance Sheet Fund Investment
•Targets that expand our:
• Specialty offerings
•End market presence
•Geographic footprint
•Operating Margin
• Synergy opportunities
•Adjacent material solutions
•Expanding our sales,
marketing, and technical
capabilities
• Investing in operational and
LSS initiatives (including
synergy capture)
•Manufacturing alignment Organic
Growth
Share
Repurchases
Dividends
Acquisitions
Page 13
$0.16
$0.20 $0.24
$0.32
$0.00
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
• Repurchased ~5 million
shares in 2013
• 15 million shares
are available for
repurchase under
the current
authorization
The New PolyOne: A Specialty Growth Company
2015 Target: $2.50 Adjusted EPS
Why Invest In PolyOne?
Senior management uses adjusted operating income, adjusted EPS, and working capital to assess
performance and allocate resources because senior management believes that these measures are useful in understanding current
profitability levels and that current levels may serve as a base for future performance.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for the United Kingdom.pdf
Seller has based any recommendations to Buyer upon information
that Seller considers reliable, but Seller makes no warranty as to any
results Buyer might obtain in Buyer’s use(s) for the Product.
Buyer must give Seller
written notice of the existence of each claim involving Product
(whether based in contract, breach of warranty, negligence, strict
liability, breach of statutory duty, other tort or otherwise) within the
earlier of thirty (30) days after receipt of the quantity of Product
forming the basis for the claim or applicable shelf-life expiration, if
any.
Seller’s entire liability to Buyer for damages, whether under
breach of the Terms (whether based in contract, breach of
warranty, negligence, strict liability, breach of statutory duty, other
tort or otherwise), and whether under these Terms or otherwise,
shall in no event exceed that part of the purchase price
applicable to the portion of Product giving rise to Buyer’s claim
for such damages.
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Annual%2520Report%2520for%252015%2520Tideman.pdf
Yes
Bis (2ethylhexyl) Adipate (DEHA) is a plasticizer and
component in the manufacturing of pelleted plastic
compounds, mostly for use in the manufacture of PVC
based plastic wrap.
Bis (2ethylhexyl) Adipate (DEHA) is a plasticizer and
component in the manufacturing of pelleted plastic
compounds, mostly for use in the manufacture of PVC
based plastic wrap.
The amounts and values for the
facility(ies) identified below are accurate, based on reasonable estimates using available data.
https://www.avient.com/sites/default/files/resources/POL%2520BofA%2520Basic%2520Materials%2520IR%2520Presentation%2520w%2520non-GAAP%252012%252011%25202013.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual
results to differ materially from those expressed in or implied by the forward-looking statements.
Use of Non-GAAP Measures
Page 3
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500
All time high of
$34.47
December 9th, 2013
• 16 consecutive quarters of
double digit EPS growth
• 42% CAGR adjusted EPS
expansion 2006-2012
• YTD stock price has increased
63% versus 27% growth in the
S&P
• More than six fold increase in
market cap: $0.5b $3.3b
Strategy and Execution Drive Results
Page 4
The World’s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Four Pillar Strategy
Page 5
PP&S
15%
Specialty
60%
Distribution
25%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010* 2011* 2012* 2015
Target
Ad
ju
st
ed
E
ar
ni
ng
s P
er
S
ha
re
Appliance
6%
Building &
Construction
13%
Wire & Cable
Electrical &
Electronics
4%
Consumer
Packaging
18%
Industrial
10%
Misc.
5%
HealthCare
Transportation
16%
Textiles
1%
United
States
70%
Europe
14%
Canada
8%
Asia
5%
Latin
America
3%
2012 Revenues: $4.0 Billion*
End Markets*
2012 Revenues: $4.0 Billion*
EPS
Page 6
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations
PolyOne
At A Glance
* Restated to exclude discontinued operations
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34% 43%
63%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 YTD 2013 2015
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's PP&S Distribution Specialty
Specialty OI $5M $46M $87M $153M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 YTD 2013 2015
Where we were Where we are
Organic Consolidated
Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.8% 12.8% 12 – 16%
Global Specialty Engineered
Materials 1.1% 10.8% 8.9% 12 – 16%
Designed Structures & Solutions — — 5.0% 8 – 10%
Performance Products &
Solutions 5.5% 8.0% 8.2% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 63% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 28%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
*Percentage of Specialty Platform revenue from products introduced in last five years
19.5%
44.0%
2006 Q3 2013
$20.3
$46.6
2006 TTM
Q3'13
14.3%
31.0%
2006 Q3 2013
Research & Development
Spending
Specialty Platform
Vitality Index Progression*
Innovation Drives Earnings Growth
($ millions)
Specialty Platform
Gross Margin %
Page 9
We are Experts in Polymer Science and Formulation
Polymer Science
Formulation
Chemistry
Processing
Inputs
Base Resins
Additives
Modifiers
Colorants
Specialized
Polymer Materials,
Services, and Solutions
Expertise
Satisfied
Consumers
PolyOne Customer
Innovative
Products & Services
Marketplace Demands
Performance Requirements
Value Drivers
Page 10
Positioned for Strong Growth
2015 Target
Rev: $5B
Adj.
Senior management uses adjusted operating income, adjusted EPS, and working
capital to assess performance and allocate resources because senior management believes that these measures are useful in
understanding current profitability levels and that current levels may serve as a base for future performance.